Drug Compliance (HAART)
"Adherence and Clinical Outcome with HAART in Drug Users and Non-Drug Users."
Published in AIDS Weekly, August 23rd, 1999
According to an abstract submitted by the authors to the 10th Symposium on HIV Infection, held June 17-19, 1999, in Toulon, France, "Purpose of the Study: We compare adherence and clinical outcome with ... highly active antiretroviral therapy (HAART) in non-active IDUs and subjects with other HIV risk behaviors (non-IDUs). Methods: A total of 133 non-naive HIV infected adult patients, 71% IDUs and 29% non-IDUs, received triple drug therapy with stavudine, lamivudine, and indinavir. Adherence, side effects, and efficacy of treatment were assessed every 3 months. Adherence was assessed by medical appointments kept as scheduled, self-report of medications taken, and HIV...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1999-08-23)
More Articles from AIDS Weekly
- AIDS Therapies
New NNRTIs Act Against HIV Resistant To Other NNRTIs - AIDS Therapies
Potent New Nucleoside Analog May Replace Lamivudine - Arthritis (Reiter's Syndrome)
Reactive Arthritis Not Always Benign - Novel Therapeutics
Door Opens for Genetic Manipulation of the Brain - Nucleic Acid Vaccines
Self-Replicating RNA Vaccine for Cancer, Disease Therapy - AIDS Care
Largest Disease Management Contract in U.S. Signed - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
